LASER PHOTOCOAGULATION TREATMENT FOR CANDIDA CHORIORETINITIS
Related Experiment Video
Updated: Jun 12, 2025
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Robin C Su1, Ankur Mehra, Tsun-Kang Chiang
1Department of Ophthalmology and Visual Sciences, University Hospitals Eye Institute, Case Western Reserve University, Cleveland, Ohio.
Purpose:
The purpose of this article is to describe the novel surgical technique using laser photocoagulation for the management of Candida chorioretinal lesions that are refractory to medical therapy.
Methods:
This report presents the use of laser photocoagulation applied to a Candida chorioretinal lesion that was refractory to extensive systemic and intravitreal antifungal medications. The presenting lesion was in an immunosuppressed patient. Argon laser photocoagulation was applied onto and surrounding the Candida chorioretinal lesion.
Results:
After laser photocoagulation, the Candida chorioretinal lesion has remained resolved for more than 1 year with no further reactivation, extensions, or satellites.
Conclusion:
Candida chorioretinitis can be extremely therapeutically resistant. Current treatment involves systemic and intravitreal antifungals. There are currently limited options for chorioretinal lesions refractory to standard medical therapy. The authors report the novel application of laser photocoagulation as a potential treatment option in refractory cases of Candida chorioretinitis.
